Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
More was spent by Novo Nordisk on shareholder enrichment in the form of stock buybacks and dividends than on R&D, a hallmark of the financialized pharmaceutical business model
Lippi G, Franchini M, Favaloro EJ
second, most of the combination studies have been performed using exenatide, one of the least effective GLP-1RA in terms of HbA1c and body weight reduction
ACTL6A reprograms GSH metabolism to maintain GC malignant progression To identify the roles played by ACTL6A in GC, we performed an RNA array in ACTL6A-KD SNU638 cells
Delivered in 24 hours in testing
US$ 20.88
US$ 21.54
US$ 27.93
US$ 22.03
US$ 28.54
US$ 25.92
US$ 22.55
